ATE511645T1 - Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme - Google Patents
Testverfahren zum nachweis von antikörpern gegen lysosomenenzymeInfo
- Publication number
- ATE511645T1 ATE511645T1 AT07753313T AT07753313T ATE511645T1 AT E511645 T1 ATE511645 T1 AT E511645T1 AT 07753313 T AT07753313 T AT 07753313T AT 07753313 T AT07753313 T AT 07753313T AT E511645 T1 ATE511645 T1 AT E511645T1
- Authority
- AT
- Austria
- Prior art keywords
- test method
- antibodies against
- detecting antibodies
- lysosome enzymes
- lysosome
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title abstract 2
- 108090000790 Enzymes Proteins 0.000 title abstract 2
- 210000003712 lysosome Anatomy 0.000 title 1
- 230000001868 lysosomic effect Effects 0.000 title 1
- 238000010998 test method Methods 0.000 title 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000002641 enzyme replacement therapy Methods 0.000 abstract 1
- 230000002132 lysosomal effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78369006P | 2006-03-17 | 2006-03-17 | |
| PCT/US2007/006677 WO2007109155A2 (en) | 2006-03-17 | 2007-03-16 | Assays for detection of antibodies to lysosomal enzymes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511645T1 true ATE511645T1 (de) | 2011-06-15 |
Family
ID=38522987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07753313T ATE511645T1 (de) | 2006-03-17 | 2007-03-16 | Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7713709B2 (de) |
| EP (1) | EP2005166B1 (de) |
| JP (1) | JP2009529885A (de) |
| AT (1) | ATE511645T1 (de) |
| AU (1) | AU2007227437B2 (de) |
| CA (1) | CA2644343A1 (de) |
| ES (1) | ES2366059T3 (de) |
| WO (1) | WO2007109155A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138262B1 (en) | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
| US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| AU2007212021B2 (en) | 2006-02-07 | 2013-06-06 | Takeda Pharmaceutical Company Limited | Stabilized compositions of proteins having a free thiol moiety |
| US20110223147A1 (en) | 2008-05-07 | 2011-09-15 | Zystor Therapeutics, Inc. | Lysosomal targeting peptides and uses thereof |
| ES2758827T3 (es) | 2009-06-17 | 2020-05-06 | Biomarin Pharm Inc | Formulaciones para enzimas lisosómicas |
| NZ713967A (en) | 2009-07-28 | 2017-01-27 | Shire Human Genetic Therapies | Compositions and methods for treating gaucher disease |
| AU2011289426A1 (en) * | 2010-08-10 | 2013-02-28 | Amgen Inc. | Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| CA2853103C (en) * | 2011-10-21 | 2020-01-07 | Decimadx, Llc | Point-of-care immunoassay for quantitative small analyte detection |
| US9623090B2 (en) | 2012-03-02 | 2017-04-18 | Shire Human Genetic Therapies, Inc. | Compositions and methods for treating type III gaucher disease |
| EP3060917B1 (de) * | 2013-10-24 | 2019-05-15 | Siemens Healthcare Diagnostics Inc. | Assays für makromolekulare analyten |
| MX2018005258A (es) * | 2015-11-06 | 2019-09-04 | Biomarin Pharm Inc | Ensayos basados en células para la detección de anticuerpos u otros factores que neutralizan la absorción de enzimas lisosómicas. |
| CN112126672A (zh) * | 2020-08-19 | 2020-12-25 | 四川大学华西医院 | α-L-岩藻糖苷酶活性测定方法、α-L-岩藻糖苷酶诊断试剂及应用 |
| CN120202410A (zh) * | 2022-10-14 | 2025-06-24 | 桑格摩生物治疗股份有限公司 | 溶酶体贮积病的测定 |
| CN116643044B (zh) * | 2023-06-15 | 2023-12-12 | 广州贝思奇诊断试剂有限公司 | 一种基于胶体金法检测尿液中hiv-1和hiv-2抗体的试剂盒及其制备方法、应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| JP2001172298A (ja) * | 1999-12-17 | 2001-06-26 | Japan Science & Technology Corp | イヌ組換え可溶性ＩｇＥレセプターα鎖 |
| AU2001247317A1 (en) * | 2000-03-13 | 2001-09-24 | Research Foundation For Mental Hygeine, Inc. | A lysosomal pepstatin-insensitive proteinase as a novel biomarker for detecting and diagnosing breast cancer |
| US6866844B2 (en) * | 2002-11-07 | 2005-03-15 | Biomarin Pharmaceutical Inc. | Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| US6972124B2 (en) * | 2000-05-01 | 2005-12-06 | Biomarin Pharmaceuticals Inc. | Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| JP4672263B2 (ja) * | 2004-01-27 | 2011-04-20 | デンカ生研株式会社 | 簡便な検出法、検出装置及び検出キットとその製法 |
-
2007
- 2007-03-16 EP EP07753313A patent/EP2005166B1/de not_active Not-in-force
- 2007-03-16 WO PCT/US2007/006677 patent/WO2007109155A2/en not_active Ceased
- 2007-03-16 AT AT07753313T patent/ATE511645T1/de not_active IP Right Cessation
- 2007-03-16 AU AU2007227437A patent/AU2007227437B2/en not_active Ceased
- 2007-03-16 US US11/724,983 patent/US7713709B2/en active Active
- 2007-03-16 CA CA002644343A patent/CA2644343A1/en not_active Abandoned
- 2007-03-16 JP JP2009500514A patent/JP2009529885A/ja not_active Ceased
- 2007-03-16 ES ES07753313T patent/ES2366059T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2644343A1 (en) | 2007-09-27 |
| US20080003626A1 (en) | 2008-01-03 |
| EP2005166B1 (de) | 2011-06-01 |
| WO2007109155A3 (en) | 2007-12-21 |
| ES2366059T3 (es) | 2011-10-14 |
| JP2009529885A (ja) | 2009-08-27 |
| EP2005166A2 (de) | 2008-12-24 |
| AU2007227437A1 (en) | 2007-09-27 |
| US7713709B2 (en) | 2010-05-11 |
| AU2007227437B2 (en) | 2013-01-17 |
| HK1121530A1 (en) | 2009-04-24 |
| WO2007109155A2 (en) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE511645T1 (de) | Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme | |
| WO2010031056A3 (en) | Methods and compositions for modulating ire1, src, and abl activity | |
| SI1935331T1 (sl) | Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode | |
| PH12018500045A1 (en) | Compositions and methods for treating and diagnosing asthma | |
| ATE457773T1 (de) | Mittel zur funktionalen wiederherstellung eines geschädigten nervensystems | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| WO2008063511A3 (en) | Methods for treating pompe disease | |
| EP4032538A3 (de) | Verfahren und produkte zur in-vivo-enzymprofilierung | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| WO2008108803A3 (en) | Immune cell biosensors and methods of using same | |
| WO2008042231A3 (en) | Compositions and methods for evaluating and treating heart failure | |
| EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| WO2008073177A3 (en) | Expression profiles associated with irinotecan treatment | |
| WO2008033427A3 (en) | Compositions and methods for detection of lysosomal storage disease | |
| EP2423684A3 (de) | Profilbestimmungsanalyse der differentiellen Expression von Zellkulturph. und Verwendung damit | |
| MY144970A (en) | Heterocyclic compounds | |
| SG155931A1 (en) | Wnt proteins and detection and treatment of cancer | |
| DE602005012481D1 (de) | 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck | |
| WO2005074655A3 (en) | Materials and method for promotion of nerve regeneration | |
| MX2008009821A (es) | Materiales fibrosos no tejidos y electrodos a partir de estos. | |
| WO2006074450A3 (en) | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases | |
| WO2006109301A3 (en) | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases | |
| WO2007088051A3 (en) | Modulation of mdl-1 activity for treatment of inflammatory disease | |
| ATE489628T1 (de) | Galk1s als modifikatoren des pten/akt-wegs | |
| WO2007057548A3 (fr) | Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |